These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 10467194)
21. Comparison of paclitaxel drug-eluting balloon and paclitaxel-eluting stent in small coronary vessels in diabetic and nondiabetic patients - results from the BELLO (balloon elution and late loss optimization) trial. Giannini F; Latib A; Jabbour RJ; Costopoulos C; Chieffo A; Carlino M; Montorfano M; Menozzi A; Castriota F; Micari A; Cremonesi A; De Felice F; Marchese A; Tespili M; Presbitero P; Sgueglia GA; Buffoli F; Tamburino C; Varbella F; Colombo A Cardiovasc Revasc Med; 2017; 18(1):4-9. PubMed ID: 28011243 [TBL] [Abstract][Full Text] [Related]
22. Impact of sex on clinical and angiographic outcomes among patients undergoing revascularization with drug-eluting stents. Stefanini GG; Kalesan B; Pilgrim T; Räber L; Onuma Y; Silber S; Serruys PW; Meier B; Jüni P; Windecker S JACC Cardiovasc Interv; 2012 Mar; 5(3):301-10. PubMed ID: 22440496 [TBL] [Abstract][Full Text] [Related]
23. Randomized comparison of everolimus-eluting stents and sirolimus-eluting stents in patients with ST elevation myocardial infarction: RACES-MI trial. Di Lorenzo E; Sauro R; Varricchio A; Capasso M; Lanzillo T; Manganelli F; Carbone G; Lanni F; Pagliuca MR; Stanco G; Rosato G; Suryapranata H; De Luca G JACC Cardiovasc Interv; 2014 Aug; 7(8):849-56. PubMed ID: 25147029 [TBL] [Abstract][Full Text] [Related]
24. Late-term clinical outcomes with zotarolimus- and sirolimus-eluting stents. 5-year follow-up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions). Kandzari DE; Mauri L; Popma JJ; Turco MA; Gurbel PA; Fitzgerald PJ; Leon MB JACC Cardiovasc Interv; 2011 May; 4(5):543-50. PubMed ID: 21596327 [TBL] [Abstract][Full Text] [Related]
25. One-year follow-up after primary coronary intervention for acute myocardial infarction in diabetic patients. A substudy of the STENT PAMI trial. Mattos LA; Grines CL; Sousa JE; Sousa AG; Stone GW; Cox D; Garcia E; Morice MC; O'Neill W; Grines L; Boura J Arq Bras Cardiol; 2001 Dec; 77(6):549-61. PubMed ID: 11799430 [TBL] [Abstract][Full Text] [Related]
26. A comparative analysis of major clinical outcomes using drug-eluting stents versus bare metal stents in diabetic versus nondiabetic patients. Minha S; Bental T; Assali A; Vaknin-Assa H; Lev EI; Rechavia E; Battler A; Kornowski R Catheter Cardiovasc Interv; 2011 Nov; 78(5):710-7. PubMed ID: 21805561 [TBL] [Abstract][Full Text] [Related]
27. Impact of diabetes mellitus on long-term outcomes in the drug-eluting stent era. Iijima R; Ndrepepa G; Mehilli J; Markwardt C; Bruskina O; Pache J; Ibrahim M; Schömig A; Kastrati A Am Heart J; 2007 Oct; 154(4):688-93. PubMed ID: 17892992 [TBL] [Abstract][Full Text] [Related]
28. Persistent coronary no flow after wire insertion is an early and readily available mortality risk factor despite successful mechanical intervention in acute myocardial infarction: a pooled analysis from the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials. Valgimigli M; Campo G; Malagutti P; Anselmi M; Bolognese L; Ribichini F; Boccuzzi G; de Cesare N; Rodriguez AE; Russo F; Moreno R; Biondi-Zoccai G; Penzo C; Díaz Fernández JF; Parrinello G; Ferrari R JACC Cardiovasc Interv; 2011 Jan; 4(1):51-62. PubMed ID: 21251629 [TBL] [Abstract][Full Text] [Related]
29. [Primary angioplasty in acute myocardial infarct with or without a stent implant: the experience and results at 6 months in the first 200 patients]. Galli M; Zerboni S; Politi A; De Nittis G; Bonatti R; Jemoli R; Molteni S; Tettamanti F; Ferrari G G Ital Cardiol; 1999 Mar; 29(3):261-8. PubMed ID: 10231671 [TBL] [Abstract][Full Text] [Related]
30. Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty. Al Suwaidi J; Holmes DR; Salam AM; Lennon R; Berger PB Am Heart J; 2004 May; 147(5):815-22. PubMed ID: 15131536 [TBL] [Abstract][Full Text] [Related]
31. A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in bifurcation lesions treated with a single-stenting technique: six-month angiographic and 12-month clinical results of the drug-eluting balloon in bifurcations trial. Stella PR; Belkacemi A; Dubois C; Nathoe H; Dens J; Naber C; Adriaenssens T; van Belle E; Doevendans P; Agostoni P Catheter Cardiovasc Interv; 2012 Dec; 80(7):1138-46. PubMed ID: 22422607 [TBL] [Abstract][Full Text] [Related]
32. Coronary stenting in diabetics: immediate and mid-term clinical outcome. Joseph T; Fajadet J; Jordan C; Cassagneau B; Laborde JC; Laurent JP; Marco J Catheter Cardiovasc Interv; 1999 Jul; 47(3):279-84. PubMed ID: 10402276 [TBL] [Abstract][Full Text] [Related]
34. Impact of diabetes on the benefits from everolimus-eluting stent as compared to first-generation drug-eluting stent in patients with ST elevation myocardial infarction. De Luca G; Sauro R; Capasso M; Lanzillo T; Manganelli F; Carbone G; Lanni F; Pagliuca MR; Palmieri V; Serino V; Rosato G; Suryapranata H; Di Lorenzo E Diab Vasc Dis Res; 2015 Sep; 12(5):306-14. PubMed ID: 26150193 [TBL] [Abstract][Full Text] [Related]
35. Second-versus first-generation "Limus"-eluting stents in diabetic patients with coronary artery disease: a randomized comparison in setting of ISAR-TEST-4 trial. Kufner S; Byrne RA; Mehilli J; Massberg S; Birkmeier KA; Schulz S; Pache J; Schömig A; Kastrati A Catheter Cardiovasc Interv; 2013 Nov; 82(6):E769-76. PubMed ID: 23754254 [TBL] [Abstract][Full Text] [Related]
37. Comparative efficacy of primary angioplasty with stent implantation and thrombolysis in restoring basal coronary artery flow in acute ST segment elevation myocardial infarction: quantitative assessment using the corrected TIMI frame count. Vrachatis AD; Alpert MA; Georgulas VP; Nikas DJ; Petropoulou EN; Lazaros GI; Michelakakis NA; Karavidis AI; Lakoumentas JA; Stergiou L; Zacharoulis AA Angiology; 2001 Mar; 52(3):161-6. PubMed ID: 11269778 [TBL] [Abstract][Full Text] [Related]
38. Insulin-treated diabetes mellitus and predictors of mid-term clinical outcome after percutaneous coronary interventions with stent implantation. Tarantini G; Briguori C; Stankovic G; Takagi T; Corvaja N; Di Mario C; Colombo A Ital Heart J; 2003 Dec; 4(12):843-9. PubMed ID: 14976848 [TBL] [Abstract][Full Text] [Related]
39. Coronary stent implantation in diabetic versus nondiabetic patients. Early and late outcomes. Bayerl DM; Siqueira E; Moscoso I; Santos E; Maeda A; Bittencourt O; Mauro MF; Cristovão S; Salman A; Sanches G; Mangione JA Arq Bras Cardiol; 2000 Nov; 75(5):365-8. PubMed ID: 11080748 [TBL] [Abstract][Full Text] [Related]
40. Effect of bare metal stenting on angiographic and clinical outcomes in diabetic and nondiabetic patients undergoing percutaneous coronary intervention of nonacute occluded coronary arteries: a report from the Total Occlusion Study of Canada (TOSCA). Yee KM; Buller CE; Catellier D; Cohen EA; Carere RC; Anderson T; Berger P; Burton JR; Barbeau G; Teo KK; Dzavik V; Catheter Cardiovasc Interv; 2005 Oct; 66(2):178-84. PubMed ID: 15977265 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]